The Sphingosine 1-Phosphate Receptor Subtype-1 Is the Primary Target of Fingolimod in the CNS: Interruption of the Pro-inflammatory S1P-S1P1 Cascade

被引:0
|
作者
Brinkmann, Volker [1 ]
Streiff, Markus [1 ]
Kaupmann, Klemens [1 ]
Billich, Andreas [1 ]
Faller, Thomas [1 ]
Bollbuck, Birgit [2 ]
Bigaud, Marc [1 ]
Quancard, Jean [3 ]
Kinzel, Bernd [4 ]
机构
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Pharma AG, BOLLBUCK, GDC ATIRA LAB, Basel, Switzerland
[3] Novartis Pharma AG, QUANCARD, CPC EPP MCH LAB, Basel, Switzerland
[4] Novartis Pharma AG, DMP Anim Engn, Lab Kinz, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P05145
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Primary target of fingolimod in the CNS and its role in pro-inflammatory cascade: sphingosine 1-phosphate receptor subtype-1 (S1P1)
    Brinkmann, V.
    Kaupmann, K.
    Billich, A.
    Faller, T.
    Bollbuck, B.
    Bigaud, M.
    Quancard, J.
    Guerini, D.
    Streiff, M.
    JOURNAL OF NEUROLOGY, 2013, 260 : S225 - S226
  • [2] Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease
    Martinez-Gardeazabal, Jonatan
    Pereira-Castelo, Gorka
    Moreno-Rodriguez, Marta
    Llorente-Ovejero, Alberto
    Fernandez, Manuel
    Fernandez-Vega, Ivan
    Manuel, Ivan
    Rodriguez-Puertas, Rafael
    NEUROBIOLOGY OF DISEASE, 2024, 202
  • [3] Palmitoylation of the sphingosine 1-phosphate receptor S1P1 and sphingosine kinase
    Kihara, A.
    Ohno, Y.
    Igarashi, Y.
    CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 143 (1-2) : 99 - 99
  • [4] Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
    Groves, Aran
    Kihara, Yasuyuki
    Chun, Jerold
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 328 (1-2) : 9 - 18
  • [5] Sphingosine 1-phosphate (S1P) Physiology and the effects of S1P receptor modulation
    Hla, Timothy
    Brinkmann, Volker
    NEUROLOGY, 2011, 76 (08) : S3 - S8
  • [6] Sphingosine 1-Phosphate Receptor Subtype 1 (S1PR1) as a Therapeutic Target for Brain Trauma
    Cuzzocrea, Salvatore
    Doyle, Timothy
    Campolo, Michela
    Paterniti, Irene
    Esposito, Emanuela
    Farr, Susan A.
    Salvemini, Daniela
    JOURNAL OF NEUROTRAUMA, 2018, 35 (13) : 1452 - 1466
  • [7] Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
    Chiba, Kenji
    Maeda, Yasuhiro
    Seki, Noriyasu
    Kataoka, Hirotoshi
    Sugahara, Kunio
    AIMS MOLECULAR SCIENCE, 2014, 1 (04): : 162 - 182
  • [8] Sphingosine 1-phosphate receptor subtype 1 (S1PR1) as a new therapeutic target for brain trauma
    Salvemini, Daniela
    Cuzzocrea, Salvatore
    Campolo, Michela
    Paterniti, Irene
    Esposito, Emanuela
    BRAIN INJURY, 2017, 31 (6-7) : 867 - 867
  • [9] Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia
    Gaire, Bhakta Prasad
    Lee, Chi-Ho
    Sapkota, Arjun
    Lee, Sang Yeul
    Chun, Jerold
    Cho, Hee Jun
    Nam, Tae-gyu
    Choi, Ji Woong
    MOLECULAR NEUROBIOLOGY, 2018, 55 (03) : 2320 - 2332
  • [10] Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia
    Bhakta Prasad Gaire
    Chi-Ho Lee
    Arjun Sapkota
    Sang Yeul Lee
    Jerold Chun
    Hee Jun Cho
    Tae-gyu Nam
    Ji Woong Choi
    Molecular Neurobiology, 2018, 55 : 2320 - 2332